Inventor · disambiguated record
Dan Segal
Also filed as: SEGAL DAN
3 granted patents·11 pending applications·1 citations·filing 2016–2025
49Inventor score
Files withALTO NEUROSCIENCE INC8APPLIED MATERIALS ISRAEL LTD2UVEYE LTD2ALTOS NEUROSCIENCE INC1INTRAPOSITION LTD1
Top patents by PatentIndex Score
14 records- 0184US12249061B1Detection and estimation of defects in vehicle's exteriorUVEYE LTD·Filed 2024·Granted Mar 11, 2025·1 cites·16 claims
- 0276US12361538B1Detection and estimation of defects in vehicle's exteriorUVEYE LTD·Filed 2024·Granted Jul 15, 2025·0 cites·11 claims
- 0369US2024307377A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0464US2024307376A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0563US2023117508A1Enhancement of camp signaling as a combination drug strategy for the treatment of psychiatric and neurological disorders in which depressive, anhedonia, motivation-related or cognition-related dysfunction existsALTO NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0661US2024342165A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0758US2024342164A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0858US2022226302A1Enhancement of camp signaling as a combination drug strategy for the treatment of depression and related conditionsALTOS NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 0957US2025391707A1Method and system for 3d reconstruction of wafer structure by diagonal millingAPPLIED MATERIALS ISRAEL LTD·Filed 2024·Application pending·0 cites
- 1055US2025177386A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 1154US2022387424A1Method of treatment of depressed patients with poor cognition and selection of other patients benefiting from a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 1249US2022226331A1Integration of molecular mechanisms in the striatum as a combination drug strategy for the treatment of psychiatric and neurological disorders in which anhedonia or motivation-related dysfunction existsALTO NEUROSCIENCE INC·Filed 2022·Application pending·0 cites
- 1339US11301987B2Determining locations of suspected defectsAPPLIED MATERIALS ISRAEL LTD·Filed 2020·Granted Apr 12, 2022·0 cites·13 claims
- 1419US2018152903A1Real-time wireless positioning system and method thereofINTRAPOSITION LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dan Segal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →